论文部分内容阅读
美国1996年的药品销售形势很好,仍以二位数的增长率增长。下面是排位前十名的企业。 (1)强生公司药品销售额为53.87亿美元,增长14.6％。该公司前九个月总销售收入为161.2亿美元。 (2)默克公司增长率为22％,前九个月销售达144.2亿美元,其中默克公司的默克-美特柯(Medco)管理保健公司在三季度的处方数增加了30％,达到5500万,对公司销售也作出了贡献。 (3)百美施贵宝公司尽管由于开博通专利到期,非专利药竞争激烈,使其销售下降了72％,但总的销售仍然增长
The pharmaceutical sales situation in the United States in 1996 was very good. It still grew at a double-digit growth rate. Here are the top ten companies in the rankings. (1) J&J’s pharmaceutical sales were US$5.387 billion, an increase of 14.6%. The company’s total sales revenue for the first nine months was US$16.12 billion. (2) Merck’s growth rate was 22%, and sales in the first nine months reached US$14.42 billion. Among them, Merck’s Medico-managed health care company increased the number of prescriptions in the third quarter by 30%. It reached 55 million and also contributed to the sales of the company. (3) Although Baimei Shibaobao’s patent expired, the competition for generic drugs was fierce, causing its sales to drop by 72%, but the total sales still increased.